卵巢癌的病死率居妇科恶性肿瘤首位,由于起病隐匿,70%以上的患者就诊时已属晚期。虽然在接受传统方法治疗初期会有反应,多数患者终将复发或对化学治疗药物产生耐药,因此,探索新的治疗方法对于改善卵巢癌患者临床结局具有重要意义。随着基础研究的不断深入,包括免疫治疗和基因治 The mortality of ovarian cancer ranks the first place in gynecologic malignancies. Because of the insidious onset, more than 70% of patients are already in advanced stage of treatment. Although there is a response during the initial treatment of traditional methods and most patients will eventually relapse or become resistant to chemotherapeutic drugs, it is of great significance to explore new therapies to improve the clinical outcomes of patients with ovarian cancer. With the deepening of basic research, including immunotherapy and gene therapy